Bizhi Shi

Title: The Innovative Contributions of Bizhi Shi

Introduction

Bizhi Shi is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biomedical engineering. He holds a total of five patents, showcasing his expertise and innovative spirit in developing advanced therapeutic technologies.

Latest Patents

Among his latest patents is a groundbreaking invention related to chimeric antigen receptors targeting GPC3. This patent describes a nucleic acid encoding a chimeric antigen receptor expressed on the surface of T lymphocytes. The receptor comprises an extracellular binding domain, a transmembrane region, and an intracellular signaling domain. The extracellular binding domain includes a single-chain antibody, scFv(GPC3), which specifically recognizes the C-terminal epitope of GPC3. Another notable patent involves nucleic acids encoding chimeric antigen receptor proteins that bind to the epidermal growth factor receptor (EGFR). This invention details a chimeric antigen receptor protein that is expressed on the surface of human T lymphocytes, designed for specific recognition of amino acid epitopes of EGFR.

Career Highlights

Bizhi Shi has made significant strides in his career, working with esteemed organizations such as the Shanghai Cancer Institute and Carsgen Therapeutics Limited. His work has focused on developing innovative therapies that leverage the power of the immune system to combat cancer.

Collaborations

Throughout his career, Bizhi Shi has collaborated with notable colleagues, including Zonghai Li and Hua Jiang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Bizhi Shi's contributions to the field of biomedical engineering and his innovative patents highlight his role as a leading inventor in cancer therapy. His work continues to inspire advancements in medical science and improve treatment options for patients.